To establish the relevance of the cellular context and/or PML-RARα expression for the different effects afforded by S100A3 silencing in NB4 and SK-BR-3/A549, we considered the HL-60 AML cell line. The gene discussed is S100A3; the disease is acute myeloid leukemia.